The drug industry is struggling to find ways of engaging with consumers on social media. Failure to adapt may bring substantial opportunity costs, argues Virginia Hughes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pew Research Internet Project. Social Networking Fact Sheet. http://www.pewinternet.org/fact-sheets/social-networking-fact-sheet/ (January 23–26, 2014).
Pew Research Internet Project. Health Online 2013. http://www.pewinternet.org/2013/01/15/health-online-2013/ (January 15, 2013).
Health, I.M.S. Engaging Patients Through Social Media. http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IIHI_Social_Media_Report_2014.pdf (January, 2014).
Davies, M. Listening to Consumers in a Highly Regulated Environment. http://www.nielsen.com/content/dam/corporate/us/en/newswire/uploads/2009/11/Nielsen-Online-Healthcare-Practice_Social-Media-Adverse-Event-Reporting_nov09.pdf (Nielson Online, August, 2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hughes, V. Social storm. Nat Biotechnol 33, 14–17 (2015). https://doi.org/10.1038/nbt.3106
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3106
This article is cited by
-
Increasing patient participation in drug development
Nature Biotechnology (2015)